In a new study, poor sleep was linked to an increased risk of life-threatening flare-ups in people with chronic obstructive pulmonary disease (COPD).
An observational study1 supported by the National Institutes of Health found that poor sleep was associated with a significantly increased risk of life-threatening flare-ups in patients with chronic obstructive pulmonary disease (COPD).
The study included 1647 people with confirmed COPD who enrolled in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS), which is a multicenter, US longitudinal study that was designed to evaluate COPD subpopulations, outcomes, and biomarkers.
All participants were current or former tobacco smokers with confirmed COPD. Each participant also had 1 sleep evaluation on enrollment. Researchers evaluated COPD flare-ups over a 3-year follow-up period for each patient and compared the measurements against sleep quality of each participant. Sleep duration, timing of sleep, and frequency of disturbances were included in the analysis of self-reported sleep quality.
The researchers adjusted for socio-environmental exposures with the Area Deprivation Index, which is a composite measure of neighborhood quality, and the Adversity-Opportunity Index, which is a composite measure of individual-level historic and current socioeconomic indicators.
Poor sleep quality was associated with more COPD flare-ups compared with those with the best quality of sleep. Patients at the threshold or base level of poor sleep had a 25% increased risk of having a COPD flare-up within a year. Patients with the worst sleep quality had a 95% increased risk of having a COPD exacerbation in the next year.
The study also found that increasing Pittsburgh Sleep Quality Index Scores were associated with a 5% increased risk of exacerbation per point in the dataset.
Aaron Baugh, the lead study author, said that these results have implications on Black Americans who generally have poorer sleep quality than other races and ethnicities in a news release.2 Poor sleep is now linked to COPD, which may explain why Black Americans tend to do worse when diagnosed with COPD compared with other racial and ethnic groups.
Marishka Brown, director of the NHLBI’s National Center on Sleep Disorders Research, said “This study adds to a growing base demonstrating the harmful effects of poor sleep on health in general but can be particularly damaging in people with devastating preexisting conditions, such as COPD.”
References
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More